United States - English - NLM (National Library of Medicine)

usantibiotics, llc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin and clavulanate potassium is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: - lower respiratory tract infections - caused by beta‑lactamase–producing isolates of haemophilus influenzae and moraxella catarrhalis . - acute bacterial otitis media - caused by beta‑lactamase–producing isolates of h. influenzae and m. catarrhalis . - sinusitis - caused by beta‑lactamase–producing isolates of h. influenzae and m. catarrhalis . - skin and skin structure infections - caused by beta‑lactamase–producing isolates of staphylococcus aureus , escherichia coli , and klebsiella species. - urinary tract infections - caused by beta‑lactamase–producing isolates of e. coli , klebsiella species, and enterobacter species. limitations of use when susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium shou

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 500mg - amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - granules for suspension - 125mg - amoxicillin (amoxicillin trihydrate) 125mg - aminopenicillins

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - granules for suspension - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Canada - English - Health Canada

apotex inc - amoxicillin (amoxicillin trihydrate) - capsule - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Canada - English - Health Canada

apotex inc - amoxicillin (amoxicillin trihydrate) - capsule - 500mg - amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins

Canada - English - Health Canada

apotex inc - amoxicillin (amoxicillin trihydrate) - powder for suspension - 125mg - amoxicillin (amoxicillin trihydrate) 125mg - aminopenicillins

Canada - English - Health Canada

apotex inc - amoxicillin (amoxicillin trihydrate) - powder for suspension - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium tablets usp, amoxicillin and clavulanate potassium for oral suspension usp, and amoxicillin and clavulanate potassium tablets usp (chewable) and other antibacterial drugs, amoxicillin and clavulanate potassium tablets usp, amoxicillin and clavulanate potassium for oral suspension usp, and amoxicillin and clavulanate potassium tablets usp (chewable) should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. amoxicillin and clavulanate potassium tablets usp, amoxicillin and clavulanate potassium for oral suspension usp, and amoxicillin and clavulanate potassium tablets usp (c